Clinical Advances and Perspectives in Targeted Radionuclide Therapy

Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine subspecialty. For many decades, treatment with radionuclides has been mainly restricted to the use of iodine-131 in thyroid disorders. Currently, radiopharmaceuticals, consisting of a radionuclide coupled to a vect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lepareur, Nicolas, Ramée, Barthélémy, Mougin-Degraef, Marie, Bourgeois, Mickaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303056/
https://www.ncbi.nlm.nih.gov/pubmed/37376181
http://dx.doi.org/10.3390/pharmaceutics15061733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303056/
https://www.ncbi.nlm.nih.gov/pubmed/37376181
http://dx.doi.org/10.3390/pharmaceutics15061733

Ejemplares similares